Holen Sie sich die Stockscreener-App
1.39
1.42%
-0.02
Handel nachbörslich:
1.32
-0.07
-5.04%
Cardiol Therapeutics Inc Aktie (CRDL) Neueste Nachrichten
Cardiol Therapeutics (CRDL) Receives 'Buy' Rating from Canaccord Genuity | CRDL Stock News - gurufocus.com
Cardiol Therapeutics (NASDAQ:CRDL) Earns "Buy" Rating from Canaccord Genuity Group - MarketBeat
Cardiol Therapeutics (NASDAQ:CRDL) Raised to Hold at Wall Street Zen - MarketBeat
What is HC Wainwright's Estimate for CRDL FY2028 Earnings? - MarketBeat
CARDIOL THERAPEUTICS INC (CRDL.NE) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
CRDL Stock Price, Quote & Chart | CARDIOL THERAPEUTICS INC-A (NASDAQ:CRDL) - ChartMill
Merger Talk: Will Cardiol Therapeutics Inc outperform the market in YEAR2026 Analyst Calls & High Accuracy Investment Signals - baoquankhu1.vn
Cardiol surpasses 50% enrollment in phase III pericarditis trial By Investing.com - Investing.com Australia
Cardiol Therapeutics (NASDAQ:CRDL) Posts Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat
Cardiol Therapeutics Details 2025 Progress and Funding for Late-Stage Cardiac Drug Programs - tipranks.com
Cardiol Therapeutics initiated pivotal Phase III Maveric trial of Cardiolrx in recurrent pericarditis - marketscreener.com
Cardiol Therapeutics Initiated Pivotal Phase Iii Maveric Trial Of Cardiolrx In Recurrent Pericarditis - TradingView
Cardiol surpasses 50% enrollment in phase III pericarditis trial - investing.com
Cardiol Therapeutics (NASDAQ: CRDL) advances 2025 cardiac trials and funding - Stock Titan
Heart drug trial passes halfway mark as Cardiol funds work into 2027 - Stock Titan
Cardiol Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Cardiol Therapeutics Achieves MAVERIC Enrollment Milestone Amidst Approaching Cash Runway Deadline - bitget.com
Cardiol Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Cardiol Therapeutics (CRDL) files Form 40-F: 100.26M shares, audited 2025 results - Stock Titan
Cardiol Therapeutics Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView
Fed Meeting: Can Cardiol Therapeutics Inc maintain its current growth rateWeekly Profit Recap & Technical Buy Zone Confirmation - baoquankhu1.vn
Cardiol Therapeutics (TSE:CRDL) Trading Up 10.5%Time to Buy? - MarketBeat
Earnings Recap: Can Cardiol Therapeutics Inc maintain its current growth rate2026 Analyst Calls & Community Consensus Trade Alerts - baoquankhu1.vn
Total debt of Cardiol Therapeutics Inc. Class A – HAM:CT9 - TradingView
Free cash flow of Cardiol Therapeutics Inc. Class A – HAM:CT9 - TradingView
Operating income of Cardiol Therapeutics Inc. Class A – HAM:CT9 - TradingView
Taxes of Cardiol Therapeutics Inc. Class A – HAM:CT9 - TradingView
Cardiol Therapeutics (CRDL) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Cardiol Therapeutics (TSX:CRDL) Expands Research Scope In Tsx Small Cap Index - Kalkine Media
If You Invested $1,000 in Cardiol Therapeu (CRDL) - Stock Titan
Cardiol Therapeutics (TSE:CRDL) Shares Down 1.5%Time to Sell? - MarketBeat
CRDL SEC FilingsCardiol Therapeu 10-K, 10-Q, 8-K Forms - Stock Titan
Cizzle Brands Corporation Releases Fiscal Q2 2026 Results - Investing News Network
HC Wainwright & Co. Reiterates Cardiol Therapeutics (CRDL) Buy Recommendation - MSN
(CRDL) Trading Advice (CRDL:CA) - Stock Traders Daily
(CRDL) Optimized Trading Opportunities (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics Touts Phase III MAVERIC Timeline for CardiolRx at TD Cowen Healthcare Conference - MarketBeat
(CRDL) Stock Evaluation Report (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics (CRDL) Stock Analysis Report | Financials & Insights - Benzinga Japan
CRDL: Pivotal phase 3 data for CardiolRx in pericarditis expected late 2024, supporting broad expansion - TradingView
Cardiol Therapeutics (NASDAQ:CRDL) Shares Down 1%What's Next? - MarketBeat
(CRDL) Investment Performance Report (CRDL:CA)Stock Traders Daily Canada - Stock Traders Daily
Immix Biopharma to Participate in Upcoming Investor Conferences - Investing News Network
Aug Highlights: Should you avoid Cardiol Therapeutics Inc stock right nowPortfolio Performance Report & High Accuracy Swing Entry Alerts - baoquankhu1.vn
(CRDL) Market Insights and Trading Signals (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics (TSE:CRDL) Trading Down 4.8%Time to Sell? - MarketBeat
Cardiol Therapeutics to Present Cardiovascular Pipeline Update at TD Cowen Health Care Conference - TipRanks
Cardiol Therapeutics (NASDAQ: CRDL) outlines heart programs at TD Cowen - Stock Titan
Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference - TMX Newsfile
Objective long/short (CRDL) Report (CRDL:CA) - Stock Traders Daily
argenx to Present at TD Cowen 46th Annual Healthcare Conference - Investing News Network
Should I trade or invest in Cardiol Therapeutics Inc.Market Activity Summary & High Conviction Trade Alerts - mfd.ru
CRDLCardiol Therapeu Latest Stock News & Market Updates - Stock Titan
(CRDL) Trading Performance and Risk Management (CRDL:CA)Stock Traders Daily Canada - Stock Traders Daily
Is Cardiol Therapeutics Inc. (CT9) stock a contrarian opportunityWeekly Trade Summary & Long-Term Safe Investment Ideas - mfd.ru
Moderna to Present at Upcoming Conferences in March 2026 - Investing News Network
Learn to Evaluate (CRDL) using the Charts (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics announces $13.5M bought-deal private placement - MSN
Trend Report: Is Cardiol Therapeutics Inc a cyclical or defensive stockExit Point & Reliable Price Breakout Signals - baoquankhu1.vn
1.35%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):